Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

China National Biotec and Riboxx Set Up Research Collaboration

publication date: Mar 6, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
China National Biotec Group announced a research collaboration with Riboxx Pharmaceuticals GmbH, a German biopharma. The two companies will evaluate the combination of Riboxxim®, which is a TLR3 agonist from Riboxx, and a CNBG antigen as a treatment for an infectious disease. Riboxx characterized the disease as one of the world’s deadliest, but did not name it. Riboxxim is an immune system modulator. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners